The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
Backen, Alison C
McNamara, Mairéad G
Hubner, Richard A
Valle, Juan W
AffiliationDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom
MetadataShow full item record
AbstractExpression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems.
CitationThe HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. 2018, 13 (10):e0206007 PLoS ONE